{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T09:18:31Z","timestamp":1700644711885},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/ncprheum0479","type":"journal-article","created":{"date-parts":[[2007,4,30]],"date-time":"2007-04-30T16:43:20Z","timestamp":1177951400000},"page":"282-290","source":"Crossref","is-referenced-by-count":11,"title":["Technology Insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies"],"prefix":"10.1038","volume":"3","author":[{"given":"Ingrid E","family":"Lundberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Alexanderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncprheum0479_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410160206","volume":"16","author":"K Arahata","year":"1984","unstructured":"Arahata K and Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16: 193\u2013208","journal-title":"Ann Neurol"},{"key":"BFncprheum0479_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","volume":"122","author":"PH Plotz","year":"1995","unstructured":"Plotz PH  et al. (1995) NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 122: 715\u2013724","journal-title":"Ann Intern Med"},{"key":"BFncprheum0479_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","volume":"17","author":"AG Engel","year":"1986","unstructured":"Engel AG and Arahata K (1986) Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 17: 704\u2013721","journal-title":"Hum Pathol"},{"key":"BFncprheum0479_CR4","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325: 1487\u20131498","journal-title":"N Engl J Med"},{"key":"BFncprheum0479_CR5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC and Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362: 971\u2013982","journal-title":"Lancet"},{"key":"BFncprheum0479_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"L Love","year":"1991","unstructured":"Love L  et al. (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70: 360\u2013374","journal-title":"Medicine"},{"key":"BFncprheum0479_CR7","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1001\/jama.1993.03510150080034","volume":"270","author":"FW Miller","year":"1993","unstructured":"Miller FW (1993) Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies. JAMA 270: 1846\u20131849","journal-title":"JAMA"},{"key":"BFncprheum0479_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer R  et al. (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60: 116\u2013123","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0479_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1096\/fj.04-1980com","volume":"19","author":"AJ Timmons","year":"2005","unstructured":"Timmons AJ  et al. (2005) Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J 19: 750\u2013760","journal-title":"FASEB J"},{"key":"BFncprheum0479_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/00002281-200311000-00004","volume":"15","author":"EP Hoffman","year":"2003","unstructured":"Hoffman EP  et al. (2003) New molecular research technologies in the study of muscle disease. Curr Opin Rheumatol 15: 698\u2013707","journal-title":"Curr Opin Rheumatol"},{"key":"BFncprheum0479_CR11","unstructured":"World Health Organization (2001) The International classifications of functioning, disability and health. Geneva: World Health Organization"},{"key":"BFncprheum0479_CR12","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","volume":"40","author":"FW Miller","year":"2001","unstructured":"Miller FW  et al. (2001) Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 40: 1262\u20131273","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0479_CR13","unstructured":"IMACS website [\n                    https:\/\/dir-apps.niehs.nih.gov\/imacs\/index.cfm?action=home.main\n                    \n                  ]"},{"key":"BFncprheum0479_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA  et al. (2004) International Myositis and Clinical Studies Group (IMACS) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43: 49\u201354","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0479_CR15","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1002\/art.20349","volume":"50","author":"LG Rider","year":"2004","unstructured":"Rider LG  et al. (2004) International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 50: 2281\u20132290","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE and Sherbourne CD (1992) The MOS 36-item short-form health survey: conceptual framework and item selection. Med Care 30: 473\u2013483","journal-title":"Med Care"},{"key":"BFncprheum0479_CR17","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/rheumatology\/38.7.608","volume":"29","author":"Alexanderson","year":"1999","unstructured":"Alexanderson  et al. (1999) Safety of a home exercise programme in patients with polymyositis and dermatomyositis. A pilot study. Rheumatology (Oxford) 29: 608\u2013611","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0479_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/030097400447679","volume":"29","author":"Alexanderson","year":"2000","unstructured":"Alexanderson  et al. (2000) The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 29: 295\u2013301","journal-title":"Scand J Rheumatol"},{"key":"BFncprheum0479_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/art.10053","volume":"46","author":"P Cherin","year":"2002","unstructured":"Cherin P  et al. (2002) Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis. Arthritis Rheum 46: 467\u2013474","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/ard.61.1.37","volume":"61","author":"MG Danieli","year":"2002","unstructured":"Danieli MG  et al. (2002) Cyclosporin A and intravenous immunoglobulin treatment in polymyositis\/dermatomyositis. Ann Rheum Dis 61: 37\u201341","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0479_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.10121","volume":"51","author":"UA Badrising","year":"2002","unstructured":"Badrising UA  et al. (2002) Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo. Ann Neurol 51: 369\u2013372","journal-title":"Ann Neurol"},{"key":"BFncprheum0479_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1212\/WNL.56.3.323","volume":"56","author":"MC Dalakas","year":"2001","unstructured":"Dalakas MC  et al. (2001) A controlled study of intravenous immunoglobulin combined with prednisone in treatment of IBM. Neurology 56: 323\u2013327","journal-title":"Neurology"},{"key":"BFncprheum0479_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/PL00007789","volume":"247","author":"MFG van der Meulen","year":"2000","unstructured":"van der Meulen MFG  et al. (2000) Oral pulsed high-dose dexamethasone for myositis. J Neurol 247: 102\u2013105","journal-title":"J Neurol"},{"key":"BFncprheum0479_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s004150050005","volume":"247","author":"MC Walter","year":"2000","unstructured":"Walter MC  et al. (2000) High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study. J Neurol 247: 22\u201328","journal-title":"J Neurol"},{"key":"BFncprheum0479_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000070852","volume":"50","author":"GJ Hengstman","year":"2003","unstructured":"Hengstman GJ  et al. (2003) Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary results. Eur Neurol 50: 10\u201315","journal-title":"Eur Neurol"},{"key":"BFncprheum0479_CR26","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.0.CO;2-C","volume":"10","author":"SA Spector","year":"1997","unstructured":"Spector SA  et al. (1997) Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve 10: 1242\u20131248","journal-title":"Muscle Nerve"},{"key":"BFncprheum0479_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/rheumatology\/37.2.196","volume":"37","author":"GF Wiesinger","year":"1998","unstructured":"Wiesinger GF  et al. (1998) Improvement of physical fitness and muscle strength in polymyositis\/dermatomyositis patients by a training programme. Br J Rheumatol 37: 196\u2013200","journal-title":"Br J Rheumatol"},{"key":"BFncprheum0479_CR28","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/rheumatology\/37.12.1338","volume":"37","author":"GF Wiesinger","year":"1998","unstructured":"Wiesinger GF  et al. (1998) Benefit of 6 months long-term physical training in polymyositis\/dermatomyositis patients. Br J Rheumatol 37: 1338\u20131342","journal-title":"Br J Rheumatol"},{"issue":"Suppl","key":"BFncprheum0479_CR29","first-page":"S658","volume":"54","author":"H Alexanderson","year":"2006","unstructured":"Alexanderson H  et al. (2006) Patients with chronic inflammatory myopathies have reduced muscle endurance rather than reduced muscle strength [abstract]. Arthritis Rheum 54 (Suppl): 1639: S658","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR30","first-page":"1380","volume":"23","author":"A Josefson","year":"1996","unstructured":"Josefson A  et al. (1996) A functional index in myositis. J Rheumatol 23: 1380\u20131384","journal-title":"J Rheumatol"},{"key":"BFncprheum0479_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"J Vencovsky","year":"2000","unstructured":"Vencovsky J  et al. (2000) Cyclosporine A versus methotrexate in treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29: 95\u2013102","journal-title":"Scand J Rheumatol"},{"key":"BFncprheum0479_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0031-9406(05)60764-X","volume":"87","author":"S Heikkil\u00e4","year":"2001","unstructured":"Heikkil\u00e4 S  et al. (2001) Rehabilitation in myositis. Physiotherapy 87: 301\u2013309","journal-title":"Physiotherapy"},{"key":"BFncprheum0479_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/art.21715","volume":"55","author":"H Alexanderson","year":"2006","unstructured":"Alexanderson H  et al. (2006) Functional index-2: validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum 55: 114\u2013122","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR34","first-page":"21","volume":"20","author":"KL Newcomer","year":"1993","unstructured":"Newcomer KL  et al. (1993) Validity and reliability of the timed-stands test for patients with rheumatoid arthritis and other chronic diseases. J Rheumatol 20: 21\u201327","journal-title":"J Rheumatol"},{"key":"BFncprheum0479_CR35","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/rheumatology\/kel017","volume":"45","author":"S Agarwal","year":"2006","unstructured":"Agarwal S  et al. (2006) Two simple, reliable and valid tests of proximal muscle function, and their application to the management of idiopathic inflammatory myositis. Rheumatology (Oxford) 45: 874\u2013879","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0479_CR36","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I  et al. (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47: 614\u2013622","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/ard.2003.006122","volume":"63","author":"M Fathi","year":"2004","unstructured":"Fathi M  et al. (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 63: 297\u2013301","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0479_CR38","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1148\/radiographics.20.6.g00nv031623","volume":"20","author":"JP Mayberry","year":"2000","unstructured":"Mayberry JP  et al. (2000) Thoracic manifestations of systemic autoimmune diseases: radiographic and high-resolution CT findings. Radiographics 20: 1623\u20131635","journal-title":"Radiographics"},{"key":"BFncprheum0479_CR39","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1002\/art.21240","volume":"52","author":"MR Wilkes","year":"2005","unstructured":"Wilkes MR  et al. (2005) Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52: 2439\u20132346","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR40","first-page":"61","volume":"14","author":"DW Barthel","year":"1965","unstructured":"Barthel DW and Mahoney FI (1965) Functional evaluation; the Barthel Index. Md State Med J 14: 61\u201365","journal-title":"Md State Med J"},{"key":"BFncprheum0479_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1191\/0269215503cr572oa","volume":"17","author":"C Varju","year":"2003","unstructured":"Varju C  et al. (2003) The effect of physical exercise following acute disease exacerbation in patients with dermato\/polymyositis. Clin Rehabil 17: 83\u201387","journal-title":"Clin Rehabil"},{"key":"BFncprheum0479_CR42","first-page":"2386","volume":"29","author":"H Alexanderson","year":"2002","unstructured":"Alexanderson H  et al. (2002) Development of the myositis activities profile\u2014validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis\/dermatomyositis. J Rheumatol 29: 2386\u20132392","journal-title":"J Rheumatol"},{"key":"BFncprheum0479_CR43","unstructured":"Alexanderson H  et al.: Safety and benefits of an intensive resistive exercise program in patients with stable, inactive polymyositis or dermatomyositis. Arthritis Rheum, in press"},{"key":"BFncprheum0479_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1600-0404.1979.tb02942.x","volume":"59","author":"KG Henriksson","year":"1979","unstructured":"Henriksson KG (1979) 'Semi-open' muscle biopsy technique. A simple outpatient procedure. Acta Neurol Scand 59: 317\u2013323","journal-title":"Acta Neurol Scand"},{"key":"BFncprheum0479_CR45","first-page":"1591","volume":"28","author":"C Dorph","year":"2001","unstructured":"Dorph C  et al. (2001) Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool. J Rheumatol 28: 1591\u20131599","journal-title":"J Rheumatol"},{"key":"BFncprheum0479_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V","volume":"43","author":"I Lundberg","year":"2000","unstructured":"Lundberg I  et al. (2000) Decreased expression of interleukin-1a lpha-beta and cell adhesion molecules in muscle tissue following corticosteroid treatment in polymyositis and dermatomyositis. Arthritis Rheum 43: 336\u2013348","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR47","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/art.20220","volume":"50","author":"AK Ulfgren","year":"2004","unstructured":"Ulfgren AK  et al. (2004) Down-regulation of the abberant expression of the inflammation mediator High Mobility Group Box Chromosomal Protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum 50: 1586\u20131594","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR48","first-page":"940","volume":"27","author":"P Nyberg","year":"2000","unstructured":"Nyberg P  et al. (2000) Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 27: 940\u2013948","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"BFncprheum0479_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/cei.1996.104.s1.55","volume":"104","author":"MC Dalakas","year":"1996","unstructured":"Dalakas MC (1996) Clinical benefits and immunopathological correlates of intravenous immune globulin in the treatment of inflammatory myopathies. Clin Exp Immunol 104 (Suppl 1): 55\u201360","journal-title":"Clin Exp Immunol"},{"key":"BFncprheum0479_CR50","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K  et al. (2005) Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 52: 1824\u20131835","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR51","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"S Greenberg","year":"2005","unstructured":"Greenberg S  et al. (2005) Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57: 664\u2013678","journal-title":"Ann Neurol"},{"key":"BFncprheum0479_CR52","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","volume":"168","author":"Z Tezak","year":"2002","unstructured":"Tezak Z  et al. (2002) Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 168: 4154\u20134163","journal-title":"J Immunol"},{"key":"BFncprheum0479_CR53","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/awh518","volume":"128","author":"R Raju","year":"2005","unstructured":"Raju R  et al. (2005) Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 128: 1887\u20131896","journal-title":"Brain"},{"key":"BFncprheum0479_CR54","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1073\/pnas.0236183100","volume":"100","author":"M Hofbauer","year":"2003","unstructured":"Hofbauer M  et al. (2003) Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis. Proc Natl Acad Sci USA 100: 4090\u20134095","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0479_CR55","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","volume":"65","author":"S Greenberg","year":"2005","unstructured":"Greenberg S  et al. (2005) Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 65: 1782\u20131787","journal-title":"Neurology"},{"key":"BFncprheum0479_CR56","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/art.10140","volume":"46","author":"P Englund","year":"2002","unstructured":"Englund P  et al. (2002) Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum 46: 1044\u20131455","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0479_CR57","first-page":"136","volume":"75","author":"J van der Pas","year":"2004","unstructured":"van der Pas J  et al. (2004) Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 75: 136\u2013139","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncprheum0479_CR58","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1046\/j.1365-2990.2003.00471.x","volume":"29","author":"M Civatte","year":"2003","unstructured":"Civatte M  et al. (2003) Class I MHC detection as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM). Neuropathol Appl Neurobiol 29: 546\u2013552","journal-title":"Neuropathol Appl Neurobiol"},{"key":"BFncprheum0479_CR59","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1136\/ard.2005.051086","volume":"65","author":"C Dorph","year":"2006","unstructured":"Dorph C  et al. (2006) Patient reported symptomatic muscle weakness is independent of inflammation in muscle tissue from patients with polymyositis and dermatomyositis. Ann Rheum Dis 65: 1565\u20131571","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0479_CR60","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/(SICI)1099-1492(199806\/08)11:4\/5<245::AID-NBM513>3.0.CO;2-4","volume":"11","author":"JH Park","year":"1998","unstructured":"Park JH  et al. (1998) Analysis of 31P MR spectroscopy data using artificial neural networks for longitudinal evaluation of muscle diseases: dermatomyositis. NMR Biomed 11: 245\u2013256","journal-title":"NMR Biomed"},{"key":"BFncprheum0479_CR61","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1172\/JCI114461","volume":"85","author":"FW Miller","year":"1990","unstructured":"Miller FW  et al. (1990) Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies. J Clin Invest 85: 468\u2013475","journal-title":"J Clin Invest"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0479","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:04:42Z","timestamp":1684443882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BFncprheum0479"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0479","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}